Brands
Our expertise in cultivation fuels patient wellbeing, delivering top-notch medicinal cannabis across distinct medicinal cannabis brands to cater to diverse consumer segments and improve accessibility. This dual-brand strategy widens access and maximises therapeutic impact. CINV’s mission is straightforward: use our resources for the direct betterment of patient health with superior cannabis products, serving varied needs and ensuring affordability.
Ember Pharms
Ember Pharms is a wholly-owned subsidiary of CINV. CINV plans for Ember Pharms to be the only EU-GMP-certified extraction facility in South Africa, enabling additional revenue from processing third-party flowers into oils for export. It is also the name of one of our wholly-owned brands of medical cannabis. Under the Ember Pharms brand, we prioritise affordability without compromising on quality, offering craft cannabis strains with high cannabinoid and terpene profiles at accessible prices for patients.
Ember Pharms
Our goal is to pioneer the medicinal cannabis market through premium genetics. Our state-of-the-art cultivation, harvesting, and processing facility, Ember Pharms, is located in South Africa.
Crop Circle Theraputics
For patients requiring high-potency, craft-quality cannabis, we offer Crop Circle Therapeutics. Crop Circle features CINV’s most exceptional genetics targeted to provide effective relief for a wide range of health conditions.
Supply Chain Partners
Crop Circle Theraputics
For patients requiring high-potency, craft-quality cannabis, we offer Crop Circle Therapeutics. Crop Circle features CINV’s most exceptional genetics targeted to provide effective relief for a wide range of health conditions.